Here at IMU holders assume an IP clean up in prep for a big pharma deal for IMU. Guess what, at ALA they think the same, clearing the way for a big guy t/o ALA.
What will it be in the end?
So far, IMU down, ALA up, almost all losses recovered.
A lot of speculation caused by the IMU board due to leaving holders on both sides in the dark.
What ever the real reason, the market doesn't like that way of not being informed.
I am not impressed, but let's hope that in the end we can positively say " Ah, that's why ".
GLTA
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update, page-22
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
